Resources

Publish Date
Public Comments
C4IP Public Interest Comments RE: ITC Inv. No. 337-TA-1276 – Certain Light-Based Physiological Measurement Devices and Components Thereof
Council for Innovation Promotion
Letters
C4IP Letter to House Ways & Means Subcommittee on Health RE: Hearing on Medical Innovation and Patient Access
Council for Innovation Promotion
Public Comments
C4IP Written Submission for Inv. No. 332-596
Council for Innovation Promotion
Public Comments
Public Comments on European Commission Draft SEP Regulation
Council for Innovation Promotion
Public Comments
C4IP Response to CMS Solicitation of Comments Concerning Initial Guidance on the Inflation Reduction Act’s (IRA) Medicare Drug Negotiation Program
Council for Innovation Promotion
Public Comments
C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
Council for Innovation Promotion
Public Comments
C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
Council for Innovation Promotion
Letters
C4IP Letter to Senate HELP Committee RE: The Bayh-Dole Act and 28 U.S. Code § 1498
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025)
Council for Innovation Promotion
External Resources
IP, Innovation, and American Universities, Bayh-Dole Coalition
Council for Innovation Promotion
Resources:

Resources:

C4IP Public Interest Comments RE: ITC Inv. No. 337-TA-1276 – Certain Light-Based Physiological Measurement Devices and Components Thereof,

06/05/2023

Resources:

Resources:

C4IP Letter to House Ways & Means Subcommittee on Health RE: Hearing on Medical Innovation and Patient Access,

05/10/2023

Resources:

Resources:

C4IP Written Submission for Inv. No. 332-596,

04/26/2023

Resources:

Resources:

Public Comments on European Commission Draft SEP Regulation,

04/19/2023

Resources:

Resources:

C4IP Response to CMS Solicitation of Comments Concerning Initial Guidance on the Inflation Reduction Act’s (IRA) Medicare Drug Negotiation Program,

04/14/2023

Resources:

Resources:

C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: The Bayh-Dole Act and 28 U.S. Code § 1498,

03/17/2023

Resources:

Resources:

C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037),

03/10/2023

Resources:

Resources:

C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276),

02/23/2023

Resources:

Resources:

C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025),

01/31/2023

Resources:

Resources:

IP, Innovation, and American Universities, Bayh-Dole Coalition,

01/15/2023

Scroll to Top